Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic ...

Survival outcomes in pancreatic cancer: A single-center retrospective study in a large healthcare system. Impact of palliative care on the management and outcomes of elderly pancreatic cancer patients ...

Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic ...

Medical researchers at the University of Iowa report promising progress in fighting one of the worst cancer killers. The phase-two clinical trial found that adding high-dose, intravenous vitamin C to ...

A new study has revealed “groundbreaking” results that may offer hope for pancreatic cancer patients. The common supplement vitamin C was found to have a significant impact for patients in active ...

BETTENDORF, Iowa (KWQC) - Researchers with the University of Iowa are looking into how vitamin C could help cancer patients along with their normal treatments for the top three deadliest cancers in ...

Intravenous (IV) therapy is administering fluids directly into a vein. It benefits treatment by enabling water, medication, blood, or nutrients to access the body faster through the circulatory system ...